Literature DB >> 11470392

Coffee consumption and serum aminotransferases in middle-aged Japanese men.

S Honjo1, S Kono, M P Coleman, K Shinchi, Y Sakurai, I Todoroki, T Umeda, K Wakabayashi, K Imanishi, H Nishikawa, S Ogawa, M Katsurada, K Nakagawa, N Yoshizawa.   

Abstract

We investigated the relation between coffee drinking and serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) concentrations among 7313 Japanese men receiving a health examination, excluding former alcohol drinkers and men with a history of chronic liver disease. Serum AST > 40 and/or ALT > 40 U/L was defined as liver inflammation. Adjustment was made for alcohol use, smoking, body mass index, serum marker for hepatitis virus infection, and other possible confounders. Adjusted odds ratios of liver inflammation were 1.00 (reference), 0.80, 0.69, and 0.61 for men drinking < 1, 1-2, 3-4, and > or = 5 cups of coffee daily, respectively. Among 6898 men without liver inflammation, serum AST and ALT were inversely associated with coffee consumption, and alcohol-related rise in AST was attenuated with coffee drinking. These findings suggest coffee may have an effect of suppressing the rise of serum aminotransferase, partly by inhibiting the alcohol-related elevation. Studies regarding biological mechanism are warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470392     DOI: 10.1016/s0895-4356(01)00344-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  22 in total

Review 1.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

2.  Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study.

Authors:  George Boon-Bee Goh; Wan-Cheng Chow; Renwei Wang; Jian-Min Yuan; Woon-Puay Koh
Journal:  Hepatology       Date:  2014-06-24       Impact factor: 17.425

3.  Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.

Authors:  Qian Xiao; Rashmi Sinha; Barry I Graubard; Neal D Freedman
Journal:  Hepatology       Date:  2014-10-30       Impact factor: 17.425

4.  Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C.

Authors:  Neal D Freedman; Teresa M Curto; Karen L Lindsay; Elizabeth C Wright; Rashmi Sinha; James E Everhart
Journal:  Gastroenterology       Date:  2011-03-02       Impact factor: 22.682

5.  Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress.

Authors:  Xiongwen Lv; Zhen Chen; Jun Li; Lei Zhang; Hongfeng Liu; Cheng Huang; Pengli Zhu
Journal:  Inflamm Res       Date:  2010-03-10       Impact factor: 4.575

6.  The genetic architecture of liver enzyme levels: GGT, ALT and AST.

Authors:  Jenny H D A van Beek; Marleen H M de Moor; Eco J C de Geus; Gitta H Lubke; Jacqueline M Vink; Gonneke Willemsen; Dorret I Boomsma
Journal:  Behav Genet       Date:  2013-04-12       Impact factor: 2.805

Review 7.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

8.  Relation of coffee, green tea, and caffeine intake to gallstone disease in middle-aged Japanese men.

Authors:  H Ishizuk; H Eguchi; T Oda; S Ogawa; K Nakagawa; S Honjo; S Kono
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

9.  Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

Authors:  Neal D Freedman; James E Everhart; Karen L Lindsay; Marc G Ghany; Teresa M Curto; Mitchell L Shiffman; William M Lee; Anna S Lok; Adrian M Di Bisceglie; Herbert L Bonkovsky; John C Hoefs; Jules L Dienstag; Chihiro Morishima; Christian C Abnet; Rashmi Sinha
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

Review 10.  Natural History of Hepatitis C.

Authors:  Shilpa Lingala; Marc G Ghany
Journal:  Gastroenterol Clin North Am       Date:  2015-08-25       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.